Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Jonathan Barratt

49PUBLICATIONS

148CO-AUTHORS

NaturopathyNeurology and neuromuscular diseasesHealth and ecological risk assessmentPanel data analysisImmunogenetics (incl. genetic immunology)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (49)

Sort by Publication Date:

|Mar 29, 2026

Efficacy and Safety of Atrasentan in Patients with IgA Nephropathy Receiving Sodium-Glucose Cotransporter 2 Inhibitors: Placebo-Controlled, Crossover Trial.

Hiddo J L Heerspink, Irene L Noronha, Jose Luis Górriz

|Mar 17, 2026

Is It Time to Review How We Use Proteinuria to Define Disease Activity in Glomerular Diseases?

Fadi Fakhouri, Eva Jenny, Jonathan Barratt

|Feb 01, 2026

A plain language summary: long-term safety and effectiveness of atacicept in individuals with IgA nephropathy.

Jonathan Barratt, Kelly Chen, Richard Lafayette

|Jan 26, 2026

Test accuracy of glomerular filtration rate estimation with creatinine and cystatin C in adults with moderate chronic kidney disease: prospective cohort study.

Edmund J Lamb, Jonathan Barratt, Elizabeth Ann Brettell

|Nov 24, 2025

Individualized treatment effects of corticosteroids in IgA nephropathy.

David L Hoelscher, Nikolas Ej Schmitz, Leon Niggemeier

|Aug 22, 2025

Authors' Reply: Ravulizumab in IgA Nephropathy: A Promising Step Toward Disease Modification?

Jonathan Barratt, Youssef M K Farag, Min Yee

Pageof 9

Frequent Collaborators

6 joint publications

Richard Lafayette

5 joint publications

Chee Kay Cheung

3 joint publications

Maarten W Taal

3 joint publications

Vladimír Tesař

3 joint publications

Sung-Gyun Kim

3 joint publications

Philip Kalra

3 joint publications

Haresh Selvaskandan

2 joint publications

Tadao Akizawa

2 joint publications

Adrian Liew

2 joint publications

Yusuke Yamaguchi

Frequent Collaborators

6 joint publications

Richard Lafayette

5 joint publications

Chee Kay Cheung

3 joint publications

Maarten W Taal

3 joint publications

Vladimír Tesař

Top Related Videos

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on : May 26, 2022

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on : Jun 08, 2022

Dioscin Mediated IgA Nephropathy Alleviation by Inhibiting B Cell Activation <em>In Vivo</em> and Decreasing Galactose-Deficient IgA1 Production <em>In Vitro</em>

Dioscin Mediated IgA Nephropathy Alleviation by Inhibiting B Cell Activation <em>In Vivo</em> and Decreasing Galactose-Deficient IgA1 Production <em>In Vitro</em>

Published on : Oct 13, 2023

See more related videos

Top Related Videos

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on : May 26, 2022

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on : Jun 08, 2022

Dioscin Mediated IgA Nephropathy Alleviation by Inhibiting B Cell Activation <em>In Vivo</em> and Decreasing Galactose-Deficient IgA1 Production <em>In Vitro</em>

Dioscin Mediated IgA Nephropathy Alleviation by Inhibiting B Cell Activation <em>In Vivo</em> and Decreasing Galactose-Deficient IgA1 Production <em>In Vitro</em>

Published on : Oct 13, 2023

See more related videos